...
首页> 外文期刊>Leukemia and lymphoma >Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation.
【24h】

Telomere dynamics in myelodysplastic syndromes and acute leukemic transformation.

机译:骨髓增生异常综合症和急性白血病转化中的端粒动力学。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Myelodysplastic syndromes (MDS) are characterized by cytopenias in the blood and dysplastic features in the hematopoietic cells. Although the impact of cytogenetic abnormalities is considerable for prognosis, the exact genetic mechanism of MDS remains undetermined. In this study we assessed cytogenetic changes, microsatellite alterations, and telomere dynamics in order to obtain further insight into the pathogenesis of MDS. Thirty-three percentage of MDS patients and 60% of post-MDS acute leukemia (post-MDS AML) had de novo microsatellite changes. In the MDS phase, however, > 60% of patients showed reduction of telomere lengths without microsatellite changes, indicating that telomere reduction in most MDS patients does not seem to be directly linked to genome instability, or that reduction of telomere length does not induce microsatellite changes in the MDS phase. Some MDS patients had microsatellite changes without telomerase elevation, indicating that genome instability might accumulate during the disease progression in some MDS patients, and this condition (cellular senescence) may be related to ineffective hemopoiesis in MDS patients. In contrast, 40% of post-MDS AML patients had elevated telomerase activity with microsatellite changes, indicating that approximately 40% of patients with post-MDS AML patients had accumulation of genome instability resulting in elevated telomerase activity in an attempt to obtain genetic stability. However, the remaining MDS patients had microsatellite changes without telomerase up-regulation, suggesting that some MDS had genome instability even after leukemic transformation. Most MDS patients with elevated telomerase activity in the AML phase had elevated telomerase activity even in the MDS phase without apparent change in telomere length before and after leukemic transformation. These findings indicate that telomerase activity in the MDS phase may be independent of telomere length, although telomere shortening seems to be related to genomic instability, and this process may be linked to apoptosis of MDS cells.
机译:骨髓增生异常综合症(MDS)的特征是血液中的血细胞减少和造血细胞的发育异常。尽管细胞遗传学异常对预后的影响很大,但MDS的确切遗传机制仍未确定。在这项研究中,我们评估了细胞遗传学变化,微卫星改变和端粒动力学,以进一步了解MDS的发病机理。 33%的MDS患者和60%的MDS后急性白血病(MDS后AML)具有从头开始的微卫星变化。然而,在MDS阶段,> 60%的患者显示端粒长度减少而无微卫星变化,这表明大多数MDS患者的端粒减少似乎与基因组不稳定性没有直接关系,或者端粒长度减少不会诱导微卫星MDS阶段的变化。一些MDS患者的微卫星变化没有端粒酶升高,表明某些MDS患者在疾病发展过程中可能会积累基因组不稳定性,并且这种情况(细胞衰老)可能与MDS患者无效的造血有关。相比之下,MDS后AML患者中有40%的端粒酶活性随微卫星变化而升高,这表明MDS AML后患者中约40%的患者具有基因组不稳定的积累,导致端粒酶活性升高,从而试图获得遗传稳定性。但是,其余MDS患者的微卫星变化却没有端粒酶上调,这表明某些MDS即使在白血病转化后仍具有基因组不稳定。大多数在AML期端粒酶活性升高的MDS患者,即使在MDS期,端粒酶活性也升高,而白血病转化前后端粒长度没有明显变化。这些发现表明,尽管端粒缩短似乎与基因组不稳定性有关,但MDS期的端粒酶活性可能与端粒长度无关。该过程可能与MDS细胞凋亡有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号